Russell Investments Group
TRML

Russell Investments Group’s Tourmaline Bio TRML Stock Holding History

Russell Investments Group’s Portfolio TRML Stock Details TRML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,579
Closed -$75.5K – 4261
2025
Q3 		$75.5K Buy
+1,579
New +$43.8K ﹤0.01% 3127
2024
Q4 		– Sell
-33
Closed -$848 – 3793
2024
Q3 		$848 Buy
+33
New +$551 ﹤0.01% 3503

Russell Investments Group's TRML Position: Q4 2025 in Review

Russell Investments Group sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 1,579 shares — an estimated $75.5K sold.

Russell Investments Group first reported a position in TRML in Q3 2024 and held it in 2 quarters. The position peaked at $75.5K in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

  • Russell Investments Group reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
  • Russell Investments Group sold 1,579 Tourmaline Bio shares in Q4 2025, an estimated $75.5K.
  • Russell Investments Group first reported a position in Tourmaline Bio in Q3 2024 and held it in 2 quarters.
  • Russell Investments Group's Tourmaline Bio position peaked at $75.5K in Q3 2025.
  • 0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on Russell Investments Group's 13F filing for Q4 2025, filed 17 Feb 2026.